Crucell « Terug naar discussie overzicht

quote:

Arabica k. schreef:

Kan het "bericht" niet vinden

quote:

balletent schreef:

News Breaks
12:15 EDT CRXL, OSIP, JNJ, GSK, VRX theflyonthewall.com: TheFly's Rumor Round-Up
A few names have moved this morning due to market speculation. OSI Pharmaceuticals (OSIP) traded higher on renewed takeover chatter that GlaxoSmithKline (GSK) is eyeing the company in the low-to-mid $40 per share range. Earlier in October, Glaxo was rumored to be interested in Valeant Pharmaceuticals (VRX) and the U.K.'s SSL International. Glaxo seems to have run out of ideas, its pipeline is dry, and trading desks speculate that some takeover ideas would represent a solution to help its portfolio. Also in health care, Crucell (CRXL) is trading higher on speculation that Johnson & Johnson (JNJ) will acquire it at $32 per share. On September 28 the companies announced that J&J, through its Ortho-McNeil-Janssen Pharmaceuticals subsidiary, and Crucell, had entered into a strategic collaboration focusing on the discovery, development and commercialization of monoclonal antibodies and vaccines. :theflyonthewall.com

quote:

eddy59 schreef:

[quote=balletent]
News Breaks
12:15 EDT CRXL, OSIP, JNJ, GSK, VRX theflyonthewall.com: TheFly's Rumor Round-Up
A few names have moved this morning due to market speculation. OSI Pharmaceuticals (OSIP) traded higher on renewed takeover chatter that GlaxoSmithKline (GSK) is eyeing the company in the low-to-mid $40 per share range. Earlier in October, Glaxo was rumored to be interested in Valeant Pharmaceuticals (VRX) and the U.K.'s SSL International. Glaxo seems to have run out of ideas, its pipeline is dry, and trading desks speculate that some takeover ideas would represent a solution to help its portfolio. Also in health care, Crucell (CRXL) is trading higher on speculation that Johnson & Johnson (JNJ) will acquire it at $32 per share. On September 28 the companies announced that J&J, through its Ortho-McNeil-Janssen Pharmaceuticals subsidiary, and Crucell, had entered into a strategic collaboration focusing on the discovery, development and commercialization of monoclonal antibodies and vaccines. :theflyonthewall.com


[/quote]
Crucell (CRXL) is trading higher on speculation that Johnson & Johnson (JNJ) will acquire it at $32 per share

Waar kunnen we zien dat its trading higher????
US was lower.
After hours?????
Calls ???

quote:

TraderRon schreef:

Ehh waarom zouden ze eerst 18% nemen.. Om vervolgens al voordat de aandelen geplaatst zijn hem helemaal over te nemen..
Das wel een grote swing opeens?

quote:

eddy59 schreef:

...
Crucell (CRXL) is trading higher on speculation that Johnson & Johnson (JNJ) will acquire it at $32 per share

Waar kunnen we zien dat its trading higher????
US was lower.
After hours?????
Calls ???

quote:

balletent schreef:

AH gisteren +1,2%

quote:

eddy59 schreef:

[quote=balletent]
AH gisteren +1,2%
[/quote]
Wat was het volume after hours???

quote:

aossa schreef:

[quote=eddy59]
[quote=balletent]
News Breaks
12:15 EDT CRXL, OSIP, JNJ, GSK, VRX theflyonthewall.com: TheFly's Rumor Round-Up
A few names have moved this morning due to market speculation. OSI Pharmaceuticals (OSIP) traded higher on renewed takeover chatter that GlaxoSmithKline (GSK) is eyeing the company in the low-to-mid $40 per share range. Earlier in October, Glaxo was rumored to be interested in Valeant Pharmaceuticals (VRX) and the U.K.'s SSL International. Glaxo seems to have run out of ideas, its pipeline is dry, and trading desks speculate that some takeover ideas would represent a solution to help its portfolio. Also in health care, Crucell (CRXL) is trading higher on speculation that Johnson & Johnson (JNJ) will acquire it at $32 per share. On September 28 the companies announced that J&J, through its Ortho-McNeil-Janssen Pharmaceuticals subsidiary, and Crucell, had entered into a strategic collaboration focusing on the discovery, development and commercialization of monoclonal antibodies and vaccines. :theflyonthewall.com


[/quote]
Crucell (CRXL) is trading higher on speculation that Johnson & Johnson (JNJ) will acquire it at $32 per share

Waar kunnen we zien dat its trading higher????
US was lower.
After hours?????
Calls ???[/quote]
Ze kijken in hun glazen bol... (maandag hoger dus).